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ABSTRACT
An 84-year-old woman had five episodes of pneumonia in 4 months. Despite extensive comorbidities and advanced age, her health status was 
good and the recurrence seemed unjustified. Exhaustive background investigation revealed 14 episodes of right-sided pneumonias during 
the 3 previous years and an inconclusive investigation with CT of the thorax and bronchofibroscopy, despite some fibrotic and atelectasic 
alterations in the right middle lobe. A new right-sided x-ray showed a wedge-shaped density extending anteriorly and inferiorly from the 
hilum, and CT of the thorax revealed aggravated middle lobe abnormalities with thickening of the bronchial wall and segment atelectasis, 
without any visible airway obstruction. After extensive work-up had excluded other causes of recurrent pneumonia and immunodeficiency, 
a non-obstructive middle lobe syndrome (MLS) was deemed responsible for the repeated episodes of pneumonia. MLS is characterised by 
chronic hypoventilation and atelectasis of the middle lobe, facilitating secretion accumulation, chronic inflammation and repeated infection. 
After treatment with bronchodilators and immunostimulants was initiated, the patient experienced no recurrences for several months.
LEARNING POINTS
• Recurrent pneumonia is common and has several possible causes. Investigation should be directed by whether or not the location of the 
episodes varies, suggesting a systemic condition or a local abnormality, respectively.
• Middle lobe syndrome (MLS) is characterised by chronic hypoventilation of the right middle lobe resulting in atelectasis and secretion 
accumulation, sometimes causing recurrent pneumonia, and should therefore be considered in the differential diagnosis.
• MLS is not unusual in children with asthma but is quite uncommon in the elderly despite age-related changes in the characteristics of 
airways with reduced elastic recoil and mucociliary clearance. 
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INTRODUCTION
Middle lobe syndrome (MLS) is characterised by chronic hypoventilation of the right middle lobe (RML) or lingula lobe, resulting in atelectasis, 
secretion accumulation, chronic inflammation, respiratory symptoms and recurrent infection[1]. The anatomy of the lobar bronchi favours 
transient hypoventilation due to inflammation or obstruction. It is relatively frequent in children with asthma but uncommon in older 
adults[2, 3]. We present a case of recurrent pneumonia and describe the diagnostic pathway leading to the diagnosis of non-obstructive MLS.
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CLINICAL CASE
An 84-year-old Caucasian woman was admitted to the Internal Medicine department due to pneumonia. She recovered well but had 
apparent bacteraemia the night before her planned discharge, prompting new blood tests, urinalysis and an x-ray of the thorax. All results 
were normal and the patient was released. However, she returned 5 days later in respiratory failure with acute pulmonary oedema and 
extensive right-sided pneumonia. This was the fifth episode in the last 4 months.
The patient had considerable comorbidities including heart failure due to ischaemic cardiomyopathy, arterial hypertension, type 2 diabetes 
mellitus and chronic kidney disease. Nonetheless, her clinical status was good, so this raised some red flags and an extensive background 
investigation was conducted and showed 14 episodes of pneumonia over the previous 3 years. The patient had already undergone CT of 
the thorax and bronchofibroscopy 18 month previously. The first showed atelectasis of the lateral segment of the RML with irregularity of 
the corresponding bronchi without any occluding formation, while the latter provided no relevant information as biopsies, bronchial lavage, 
aspirate and microbiology were all normal/negative. The lung collapse was deemed passive and the patient was referred for short-term 
respiratory kinesiotherapy. However, she continued to worsen, with progressively shorter intervals between episodes.
Imaging was repeated. A right-sided thoracic x-ray showed a wedge-shaped density extending anteriorly and inferiorly from the hilum, while 
CT of the thorax showed exposed thickening of the RML bronchi with discrete bronchiectasis and considerable atelectasis of the lobe. An 
echocardiogram showed no signs of endocarditis (Fig. 1 and 2). Known causes of chronic pneumonia were excluded by serial blood cultures 
for mycobacteria and fungi[4, 5], and serology for Coxiella burnetii, Mycoplasma pneumoniae, Legionella pneumophila, Chlamydophila pneumoniae 
and Mycobacterium spp.HIV infection, autoimmune diseases, complement and immunoglobulin deficiencies were also excluded[6].
In light of the recurrent pneumonia, the first step was to determine if repeated infections were due to immunodeficiency, chronic infection 
or morphological abnormality. The recurrent location suggested the latter, as did the examinations showing persistent atelectasis of the 
RML, consistent with MLS, and the exclusion of common chronic infections and immunodeficiencies. The second phase was to determine 
the type of MLS and search for a treatable cause[4, 5, 7]. The investigations did not suggest an obstruction in accordance with the previous 
bronchofibroscopy. A new bronchofibroscopy was deemed unnecessary given the short amount of time that had passed and the previous 
unremarkable findings.
Non-obstructive MLS was diagnosed and bronchodilators, mucolytics and immunostimulants were initiated, with good tolerability. The 
patient had no infectious episodes for 6 months, until her death from unrelated causes. Despite her short survival, the treatment considerably 
improved her quality of life.
Figure 1. Right sided thorax x-ray showing the typical wedge shaped 
density extending anteriorly and inferiorly from the hilum
Figure 2. CT of the thorax showing middle lobe atelectasis and 
bronchiectasis
DISCUSSION
Investigation of recurrent pneumonia is complex and often troublesome. The starting point should be to determine if the locations of 
the different episodes of pneumonia differ. If the sites are the same, a localized morphological abnormality or unresolved local chronic 
infection is likely, making imaging such as CT of the thorax and bronchofibroscopy a priority, as they can clarify airway patency and reveal 
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an obstruction. Bronchofibroscopy allows evaluation of small lesions invisible on CT. Biopsies should be taken of abnormal masses and 
specimens collected for pathogen identification. Localized chronic infections due to Mycobacterium, Coxiella, Mycoplasma, Actinobacteria and 
fungi such as Aspergillus and Histoplasma, should always be excluded. On the other hand, different locations suggest a systemic condition 
that weakens the patient, for instance immunodeficiency or a global ventilation disturbance such as asthma. Consideration must be given to 
chronic immunosuppressive medication. HIV, complement and immunoglobulin deficiencies should be excluded and the effect of diabetes, 
neoplasia or autoimmune diseases must be taken into account [8-11].
In our case, as the location was always the middle lobe, morphological abnormality was suspected. The CT of the thorax and bronchofibroscopy 
confirmed the chronic hypoventilation and atelectasis of the middle lobe and some discrete bronchiectasis but revealed no obstructions. As 
all causes of chronic pulmonary infection and immunodeficiency were excluded, a diagnosis of non-obstructive MLS was made. An intricate 
interaction between the diabetes immunosuppression, bronchiectasis and the known alterations in RML anatomy with age-induced airway 
changes such as decreased lung and thoracic compliance, diminished respiratory muscle strength and impaired mucociliary clearance, was 
considered to have caused pneumonia recurrence late in our patient’s life [12].
MLS was first described in 1948 by Graham et al.[3] as a chronic or recurrent collapse of the middle lobe due to hypoventilation resulting 
from mechanical obstruction or transient mucosal inflammation [2]. Limited collateral ventilation and the specific anatomy of the bronchus, 
which is narrow, long and has an acute take-off angle, are physiopathologically decisive [1, 7, 13]. There are two types of MLS, obstructive and 
non-obstructive, with the first subdivided into intrinsic or extrinsic, according to the nature of the obstruction [2]. Tumours and enlargement 
of peribronchial lymph nodes are the main causes of obstructive MLS, with transient inflammation and bronchial hyper-responsiveness 
causing non-obstructive MLS [1].
The most frequent clinical features are recurrent cough, dyspnoea, wheezing, chills, fever, haemoptysis and pneumonia [2, 13-15]. A typical 
wedge-shaped density extending antero-inferiorly from the hilum in the lateral thoracic x-ray suggests the diagnosis[1]. CT of the thorax and 
bronchofibroscopy confirm the atelectasis of the middle lobe and are used to determine if there is an obstruction, clarifying the type of MLS 
and the corresponding aetiology[1, 14].
Treatment is linked to the type of MLS. If obstructive, surgery is needed to remove the cause or the entire lobe. In non-obstructive MLS, a 
medical approach is preferred, with bronchodilator and mucolytic agents, respiratory kinesiotherapy and immunostimulants [1, 2,16-18]. 
MLS is an unusual condition without a defined frequency in the elderly population[1]. Its physiopathology and the effects of ageing on the 
respiratory system[12] suggest it is significantly underdiagnosed in this population.
